| Filed On | Filing |
|---|---|
| 09 Oct 2024 |
8-K/A: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +3 more
We have audited the accompanying consolidated balance sheets of Bioregenx, Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity (deficiency), and cash flows for th... |
Loading...
